ARIPIPRAZOLE-AU aripiprazole 5 mg tablet bottle

Active ingredient:

aripiprazole, Quantity: 5 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

aripiprazole

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; maize starch; hyprolose

Administration route:

Oral

Units in package:

100, 250

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Product summary:

Visual Identification: 5 mm, round, biconvex, white uncoated tablets with 5 debossed on one side and ZL on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2014-10-29